高鴻股份(000851.SZ)完成回購國開基金所持濟寧高鴻40%股權
格隆匯1月27日丨高鴻股份(000851.SZ)公佈,公司於2020年12月31日召開第九屆董事會第五次會議審議通過《關於公司回購下屬公司股權的議案》,同意公司以不超過6100萬元提前回購國開基金所持濟寧高鴻40%股權,並修改濟寧高鴻公司章程,本次回購完成後,國開基金將不再持有濟寧高鴻股權。
近日,公司已完成上述回購事項並辦理完成濟寧高鴻相關工商變更登記手續。本次回購支付國開基金共計6058.2萬元(其中本金6000萬元,利息58.2萬元)。本次回購完成後,國開基金不再持有濟寧高鴻股權,濟寧高鴻仍為公司的控股子公司,不會導致公司合併報表範圍發生變更,不會對公司當期損益產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.